Brinker Capital Investments’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Brinker Capital Investments’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-189,373	Closed	-$587K	–	1434
2021 Q4	$587K	Sell	189,373 -90,426	-32%	-$304K	0.01%	1000
2021 Q3	$1M	Hold	279,799	–	–	0.02%	769
2021 Q2	$1M	Buy	279,799 +36,638	+15%	+$129K	0.01%	825
2021 Q1	$951K	Buy	+243,161	New	+$1M	0.01%	719
2020 Q4	–	Sell	-217,141	Closed	-$810K	–	1255
2020 Q3	$810K	Buy	+217,141	New	+$924K	0.01%	758

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Brinker Capital Investments's BDSI Position: Q1 2022 in Review

Brinker Capital Investments sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 189,373 shares — an estimated $587K sold.

Brinker Capital Investments first reported a position in BDSI in Q3 2020 and held it in 5 quarters. The position peaked at $1M in Q3 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Brinker Capital Investments reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Brinker Capital Investments sold 189,373 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $587K.
Brinker Capital Investments first reported a position in BioDelivery Sciences International, Inc. in Q3 2020 and held it in 5 quarters.
Brinker Capital Investments's BioDelivery Sciences International, Inc. position peaked at $1M in Q3 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Brinker Capital Investments's 13F filing for Q1 2022, filed 16 May 2022.